Teva Pharmaceutical Industries ADR Reptg One Ord Shs: All Recent News

• All recent news
• Earnings news

Health-Care Picks for Contrarians 11/23/2009

A transformation of the nation’s health-care sector just took one step closer to political reality: On Saturday Senate Democrats muscled together enough votes (60-39) to send a health-care reform bill to the Senate floor for debate after Thanksgiving.Two major Senate votes remain: one to conclude the debate process and one to pass the actual bill both demanding 60 vote thresholds.The big sticking points says Arthur Henderson an analyst at Jefferies who covers the health-care sector include abortion tax increases Medicare cuts and the hotly debated public option.In a research note... Minyanville

Get Briefed: The Bulls And The Bears 11/23/2009

With Steve Forbes, Bruce Berkowitz, Jean-Marie Eveillard, Tom Gardner, John Jacquemin, Gary Shilling and Whitney Tilson. At Forbes

Five Fast-Growing Stocks to Buy 11/23/2009

HMS Holdings, Medco, Teva Pharmaceutical, DeVry and Lincoln Educational Services are rated 'buy' by TheStreet.com. At TheStreet.com

Momenta rises on upgrade ahead of Lovenox ruling 11/19/2009

NEW YORK (AP) - Shares of Momenta Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying Momenta will soon receive marketing approval for its version of the anti-clotting drug Lovenox. Associated Press

Moody's gives negative view on pharma credit 11/19/2009

NEW YORK (AP) - Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent. Associated Press

Pfizer's Generic Growth, With a Side of Sashimi 11/19/2009

A move into Japan isn't a bad idea, but it isn't going to save the company either. At Motley Fool

American Funds' Achilles' Heel 11/17/2009

Why is the fund giant losing money to competitors? At Motley Fool

$ In Search of Dividends...and More 11/17/2009

... At Barron's

Are You Ready to Make Real Money? 11/17/2009

It's time to take off the training wheels. At Motley Fool

Are You Ready to Make Real Money? 11/17/2009

It's time to take off the training wheels. Motley Fool

Five Fast-Growing Stocks to Own 11/16/2009

Stifel Financial, Medco Health Solutions, Teva Pharmaceutical and DeVry are rated 'buy.'... At TheStreet.com

When Big Tax Breaks Aren't Worth the Hassle 11/13/2009

Bad investment options and inflexibility make many reconsider tax-favored accounts. At Motley Fool

Cephalon, Barr settle Fentora dispute 11/12/2009

NEW YORK (AP) - Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday. Associated Press

The Life-and-Death Situation That Isn't 11/12/2009

Branded-drug makers aren't playing fair. At Motley Fool

What Pfizer, KKR and Goldman (Reportedly) Want: Generics! 11/12/2009

... At Wall Street Journal

More News

Market Report

News by Symbol

Today's Investing Articles

Breaking News

News by Topic

News by Industry

MSNBC News

MSN Money

Search MSN Money

Message Boards

Site Status